July 1, 2020
The Illinois Dept. of Public Health indicates that the state expects to receive 151 cases of remdesivir this week that will be allocated to hospitals.
On Monday, the U.S. Dept. of Health and Human Services announced it struck a deal with drug manufacturer Gilead to secure 500,000 additional treatment courses of remdesivir. The drug will be distributed in July, August and September, although unlike previous distributions of the medication, hospitals will be expected to purchase it from Gilead and its distributor, AmeriSource Bergen, at the negotiated price of approximately $3,200 per average treatment course.
Hospitals’ eligibility to purchase the drug will be based on hospital-reported information of currently hospitalized COVID-19 patients and the number of patients requiring treatment in intensive care units. Hospitals will be asked to report data through the TeleTracking web portal by 7:00 p.m. CDT on Monday, July 6, and every two weeks thereafter.